Health inspection·January 14, 2026

F 0605 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on medical record review, staff interview, and policy review, the facility failed to ensure residents receiving psychotropic medications were adequately monitored for effectiveness and adverse reactions. This affected five (#1, #3, #11, #19, and #22) of five residents reviewed for unnecessary medications. The facility census was 23.Findings Include: 1. Review of the medical record for Resident #1 revealed an admission date of 06/03/25 and a discharge date of 11/20/25. Diagnoses included type two diabetes mellitus, hypertension, gastro-esophageal reflux disease, Parkinson's disease, major depressive disorder, and anxiety. Review of Resident #1's Minimum Data Set (MDS) assessment dated [DATE] revealed a Brief Interview for Mental Status (BIMS) score of 13, indicating the resident was cognitively intact. Review of Resident #1's physician orders dated 06/03/25 revealed orders for Prozac (an antidepressant) 40 milligrams (mg) daily for depression related to major depressive disorder and Buspar (an antianxiety medication) 100 mg twice daily for depression related to major depressive disorder. Review of Resident #1's care plan dated 06/05/25 revealed the resident used psychotropic medications to manage depression and for behavior with depressive features. Interventions included to monitor for changes in cognition, mood, and behaviors. Review of nursing progress notes dated 06/03/25 through 11/20/25 for Resident #1 revealed no documentation of monitoring for adverse effects or effectiveness of the medications Prozac or Buspar. Review of Resident #1's medication administration records (MARs) dated 06/03/25 through 11/20/25 revealed no documentation the resident received monitoring for the effectiveness and adverse effects for the use of the medications Prozac or Buspar. 2. Review of the medical record for Resident #11 revealed an admission date of 02/26/25. Diagnoses included chronic obstructive pulmonary disease, pneumonia, hypoxemia, acute respiratory failure with hypoxia, encephalopathy, cognitive communication deficit, hyperlipidemia, anxiety, neurocognitive disorder with Lewy bodies, hypothyroidism, hypertension, syncope and collapse, hypertensive chronic kidney disease, osteoarthritis, depression, repeated falls, and cardiac arrythmia. Review of the MDS assessment dated [DATE] revealed a BIMS score of 11, indicating Resident #11's cognition was moderately impaired. Review of Resident #11's physician orders dated 02/25/25 revealed an order for Ativan (a (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 4 Event ID: 366031 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366031 B. Wing A. Building (X3) DATE SURVEY COMPLETED 01/14/2026 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Mill Manor Care Center 983 Exchange St Vermilion, OH 44089 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)